Shares of Ascletis Pharma Inc. (OTCMKTS:ASCLF – Get Free Report) dropped 18.9% during trading on Thursday . The stock traded as low as $1.54 and last traded at $1.54. Approximately 1,000 shares were traded during mid-day trading, a decline of 52% from the average daily volume of 2,092 shares. The stock had previously closed at $1.90.
Ascletis Pharma Trading Down 18.9%
The business’s 50-day moving average is $1.56 and its two-hundred day moving average is $1.13.
About Ascletis Pharma
Ascletis Pharma Inc, a biotechnology company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in Mainland China. The company offers Ritonavir tablet; and ASCLEVIR and GANOVO for the treatment of Hepatitis C virus. It is also developing ASC22 for treating CHB and HIV functional cure; ASC10 for respiratory syncytia virus; ASC10 and ASC11 to treat COVID-19; ASC40, ASC41, ASC42, ASC43F FDC for non-alcoholic steatohepatitis; and ASC42 for the treatment of primary biliary cholangitis.
Further Reading
- Five stocks we like better than Ascletis Pharma
- What Investors Need to Know to Beat the Market
- High-Flyers Near Resistance: 3 Stocks to Watch for a Dip
- What is Insider Trading? What You Can Learn from Insider Trading
- Seagate Technology Leads S&P 500: What’s Behind Its 120% Gain?
- 3 Best Fintech Stocks for a Portfolio Boost
- Vanguard’s VUG ETF: The Ultimate Growth ETF for Your Portfolio
Receive News & Ratings for Ascletis Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ascletis Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
